Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesion

Prostate

Volumn 74, Issue 2, 2014, Pages 187-200

  Bansal, Nitu ^a   Davis, Stephani ^b   Tereshchenko, Irina ^a   Budak Alpdogan, Tulin ^a   Zhong, Hua ^b   Stein, Mark N ^a,b   Kim, Isaac Yi ^a,b   Dipaola, Robert S ^a,b   Bertino, Joseph R ^a,b   Sabaawy, Hatem E ^a,b  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

prostate cancer stem cells; tumor initiating cells; zebrafish

Indexed keywords

COLLAGEN TYPE 1;

ADHERENT CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL MIGRATION; CELL RENEWAL; CONTROLLED STUDY; ELECTRORETINOGRAM; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; TUMOR MICROENVIRONMENT; XENOGRAFT; ZEBRA FISH;

PROSTATE CANCER STEM CELLS; TUMOR-INITIATING CELLS; ZEBRAFISH;

ADENOCARCINOMA; ANIMALS; CELL ADHESION; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES; TRANS-ACTIVATORS; XENOGRAFT MODEL ANTITUMOR ASSAYS; ZEBRAFISH;

EID: 84891159354     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22740     Document Type: Article

References (54)

1. Isaacs JT,. Control of cell proliferation and cell death in the normal and neoplastic prostate: A stem cell model. In:, Rodgers CHCD, Cunha G, Grayhack JT, Hinman F Jr, Horton R, editors. Benign prostatic hyperplasia. Washington, DC: US Department of Health and Human Services; 1987. pp. 85-94.
2. Isaacs JT, Kyprianou N,. Biological basis for chemohormonal therapy for prostatic cancer. Cancer Treat Res 1989; 46: 177-193.
3. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ,. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65 (23): 10946-10951.
4. Dick JE,. Stem cell concepts renew cancer research. Blood 2008; 112 (13): 4793-4807.
5. Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, Parada LF,. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012; 488 (7412): 522-526.
6. Driessens G, Beck B, Caauwe A, Simons BD, Blanpain C,. Defining the mode of tumour growth by clonal analysis. Nature 2012; 488 (7412): 527-530.
7. Schepers AG, Snippert HJ, Stange DE, van den Born M, van Es JH, van de Wetering M, Clevers H,. Lineage tracing reveals lgr5+ stem cell activity in mouse intestinal adenomas. Science 2012; 337 (6095): 730-735.
8. Ishii H, Iwatsuki M, Ieta K, Ohta D, Haraguchi N, Mimori K, Mori M,. Cancer stem cells and chemoradiation resistance. Cancer Sci 2008; 99 (10): 1871-1877.
9. Danila DC, Heller G, Gignac GA, Gonzalez-Espinoza R, Anand A, Tanaka E, Lilja H, Schwartz L, Larson S, Fleisher M, Scher HI,. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res 2007; 13 (23): 7053-7058.
10. Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG,. Hierarchical organization of prostate cancer cells in xenograft tumors: The cd44+ alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res 2007; 67 (14): 6796-6805.
11. Berezovska OP, Glinskii AB, Yang Z, Li XM, Hoffman RM, Glinsky GV,. Essential role for activation of the polycomb group (pcg) protein chromatin silencing pathway in metastatic prostate cancer. Cell Cycle 2006; 5 (16): 1886-1901.
12. Choi N, Zhang B, Zhang L, Ittmann M, Xin L,. Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation. Cancer Cell 2012; 21 (2): 253-265.
13. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM,. Recurrent fusion of tmprss2 and ets transcription factor genes in prostate cancer. Science 2005; 310 (5748): 644-648.
14. Chaux A, Albadine R, Toubaji A, Hicks J, Meeker A, Platz EA, De Marzo AM, Netto GJ,. Immunohistochemistry for erg expression as a surrogate for tmprss2-erg fusion detection in prostatic adenocarcinomas. Am J Surg Pathol 2011; 35 (7): 1014-1020.
15. Jones PH, Harper S, Watt FM,. Stem cell patterning and fate in human epidermis. Cell 1995; 80 (1): 83-93.
16. Collins AT, Habib FK, Maitland NJ, Neal DE,. Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J Cell Sci 2001; 114 (Pt 21): 3865-3872.
17. Zon LI, Peterson RT,. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 2005; 4 (1): 35-44.
18. White RM, Sessa A, Burke C, Bowman T, LeBlanc J, Ceol C, Bourque C, Dovey M, Goessling W, Burns CE, Zon LI,. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2008; 2 (2): 183-189.
19. Stoletov K, Montel V, Lester RD, Gonias SL, Klemke R,. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc Natl Acad Sci USA 2007; 104 (44): 17406-17411.
20. Nicoli S, Ribatti D, Cotelli F, Presta M,. Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res 2007; 67 (7): 2927-2931.
21. Marques IJ, Weiss FU, Vlecken DH, Nitsche C, Bakkers J, Lagendijk AK, Partecke LI, Heidecke CD, Lerch MM, Bagowski CP,. Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer 2009; 9: 128.
22. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ,. Efficient tumour formation by single human melanoma cells. Nature 2008; 456 (7222): 593-598.
23. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG,. Side population is enriched in tumorigenic, stem-like cancer cells, whereas abcg2+ and abcg2- cancer cells are similarly tumorigenic. Cancer Res 2005; 65 (14): 6207-6219.
24. Xin L, Lawson DA, Witte ON,. The sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci USA 2005; 102 (19): 6942-6947.
25. Croker AK, Goodale D, Chu J, Postenka C, Hedley BD, Hess DA, Allan AL,. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med 2009; 13 (8B): 2236-2252.
26. Tomayko MM, Reynolds CP,. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989; 24 (3): 148-154.
27. Kramer J, Granier CJ, Davis S, Piso K, Hand J, Rabson AB, Sabaawy HE,. Pdcd2 controls hematopoietic stem cell differentiation during development. Stem Cells Dev 2013; 22 (1): 58-72.
28. Sabaawy HE, Azuma M, Embree LJ, Tsai HJ, Starost MF, Hickstein DD,. Tel-aml1 transgenic zebrafish model of precursor b cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2006; 103 (41): 15166-15171.
29. Hu Y, Smyth GK,. Elda: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 2009; 347 (1-2): 70-78.
30. Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL,. Cd44+ cd24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer 2008; 98 (4): 756-765.
31. Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP, Witte ON,. Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci USA 2008; 105 (52): 20882-20887.
32. Li A, Simmons PJ, Kaur P,. Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci USA 1998; 95 (7): 3902-3907.
33. Shinohara T, Orwig KE, Avarbock MR, Brinster RL,. Spermatogonial stem cell enrichment by multiparameter selection of mouse testis cells. Proc Natl Acad Sci USA 2000; 97 (15): 8346-8351.
34. Vazquez-Martin A, Oliveras-Ferraros C, Del Barco S, Martin-Castillo B, Menendez JA,. The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells. Breast Cancer Res Treat 2010; 126 (2): 355-364.
35. Visvader JE, Lindeman GJ,. Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8 (10): 755-768.
36. Rosen JM, Jordan CT,. The increasing complexity of the cancer stem cell paradigm. Science 2009; 324 (5935): 1670-1673.
37. Vander Griend DJ, Karthaus WL, Dalrymple S, Meeker A, DeMarzo AM, Isaacs JT,. The role of cd133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res 2008; 68 (23): 9703-9711.
38. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, Collins AT,. Cd133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 2004; 117 (Pt 16): 3539-3545.
39. Taylor RA, Toivanen R, Frydenberg M, Pedersen J, Harewood L, Australian Prostate Cancer B, Collins AT, Maitland NJ, Risbridger GP,. Human epithelial basal cells are cells of origin of prostate cancer, independent of cd133 status. Stem Cells 2012; 30 (6): 1087-1096.
40. Zhou J, Wang H, Cannon V, Wolcott KM, Song H, Yates C,. Side population rather than cd133(+) cells distinguishes enriched tumorigenicity in htert-immortalized primary prostate cancer cells. Mol Cancer 2011; 10: 112.
41. Pfeiffer MJ, Schalken JA,. Stem cell characteristics in prostate cancer cell lines. Eur Urol 2009; 57 (2): 246-254.
42. Pellacani D, Packer RJ, Frame FM, Oldridge EE, Berry PA, Labarthe MC, Stower MJ, Simms MS, Collins AT, Maitland NJ,. Regulation of the stem cell marker cd133 is independent of promoter hypermethylation in human epithelial differentiation and cancer. Mol Cancer 2011; 10: 94.
43. Pellacani D, Oldridge EE, Collins AT, Maitland NJ,. Prominin-1 (cd133) expression in the prostate and prostate cancer: A marker for quiescent stem cells. Adv Exp Med Biol 2013; 777: 167-184.
44. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, Kornblum HI,. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 2003; 100 (25): 15178-15183.
45. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB,. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63 (18): 5821-5828.
46. Nowell PC,. The clonal evolution of tumor cell populations. Science 1976; 194 (4260): 23-28.
47. Mimeault M, Batra SK,. Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies. Mol Med 2011; 17 (9-10): 949-964.
48. Reya T, Morrison SJ, Clarke MF, Weissman IL,. Stem cells, cancer, and cancer stem cells. Nature 2001; 414 (6859): 105-111.
49. Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, Suri P, Wicha MS,. Hedgehog signaling and bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 2006; 66 (12): 6063-6071.
50. Bisson I, Prowse DM,. Wnt signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics. Cell Res 2009; 19 (6): 683-697.
51. O'Brien CA, Kreso A, Jamieson CH,. Cancer stem cells and self-renewal. Clin Cancer Res 2010; 16 (12): 3113-3120.
52. Goldstein AS, Drake JM, Burnes DL, Finley DS, Zhang H, Reiter RE, Huang J, Witte ON,. Purification and direct transformation of epithelial progenitor cells from primary human prostate. Nat Protoc 2011; 6 (5): 656-667.
53. Toivanen R, Berman DM, Wang H, Pedersen J, Frydenberg M, Meeker AK, Ellem SJ, Risbridger GP, Taylor RA,. Brief report: A bioassay to identify primary human prostate cancer repopulating cells. Stem Cells 2011; 29 (8): 1310-1314.
54. Risbridger GP, Taylor RA,. Minireview: Regulation of prostatic stem cells by stromal niche in health and disease. Endocrinology 2008; 149 (9): 4303-4306.